Business
Ocumetics Announces Appointment of President and CEO
(TheNewswire) Dean Burns, a 27-year Alcon Vision veteran, will lead Ocumetics through the c...
About this update from Ocumetics Technology Corp
[{"type":"text","content":"Ocumetics Announces Appointment of President and CEO\n \n \n (TheNewswire)\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Dean Burns, a 27-year Alcon Vision veteran, will lead\nOcumetics through the clinical trial and commercialization\nprocess\n \n \n \n \n Calgary, Alberta\n \n \n –\n \n \n TheNewswire -\n \n \n June 12\n \n \n , 2023\n \n \n -\nOcumetics Technology Corp.\n \n \n (TSXV:OTC)\n(OTC:OTCFF) (FRA:2QBO) (“\n \n \n Ocumetics\n \n \n ” or the “\n \n \n Corporation\n \n \n ”)\n \n \n is pleased to announce that it has\nappointed Mr. Dean Burns as Ocumetics’ President and CEO.  Mr.\nBurns will also join the Ocumetics board of directors.  Mr. Burns was\npreviously a consultant of the Corporation, assisting with the\nCorporation’s regulatory and marketing endeavours.\n \n \n Further to the announcement of Dr. Mark Lee’s resignation\neffective June 30, 2023, Dr. Lee stepped down as President and CEO on\nJune 12, 2023.\n \n \n \n \n “We are pleased to have Dean move from a consulting\ncapacity to join our team on a full-time basis in a leadership\nrole,” said Dr. Garth Webb, Chairman of the Board of Ocumetics.\n “Dean will draw on his 27 years of experience navigating the\nregulatory process and product commercialization with Alcon Vision to\nlead Ocumetics as we commence clinical trials,” added Dr.\nWebb.\n \n \n \n \n Mr. Burns is recently retired from Alcon Vision, where\nhe was a Senior Director of Cataract Instrumentation and Advanced\nConsumable Technology, a US$750 million business of Alcon.  At Alcon,\nMr. Burns managed technologies in four therapeutic categories:\nCataract, Refractive, Retinal and Pharmaceutical. Mr. Burns’\n \n \n 27-year career with Alcon brings a diverse\nhealthcare experience to Ocumetics.  His experience included\ndeveloping plans to commercialize acquired technologies and line\nextension of existing products. He also has skills and experience in\nmarketing and sales management, manufacturing, comprehensive\nunderstanding of the regulatory process for devices, Key Opinion\nLeader management, and surgeon clinical training.  Mr. Burns’\naccomplishments include over 15 FDA product approvals and five\nbusiness development and licensing acq...